Opiant Pharmaceuticals (NASDAQ:OPNT – Get Rating) and Sonoma Pharmaceuticals (NASDAQ:SNOA – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Volatility & Risk Opiant Pharmaceuticals has a beta of […]
Analysts expect Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT – Get Rating) to announce $7.13 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Opiant Pharmaceuticals’ earnings. The highest sales estimate is $10.00 million and the lowest is $5.70 million. Opiant Pharmaceuticals reported sales of $6.39 million during the same […]